TickerFacts.

Tarsus Pharmaceuticals, Inc. (TARS): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$1.59
Year ended 2025-12-31
2020-12-31: -$4.322021-12-31: -$0.672022-12-31: -$2.522023-12-31: -$4.622024-12-31: -$3.072025-12-31: -$1.59-$1.59
2020-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$1.59n/m2026-02-23, From 2025-01-01
2024-12-31-$3.07n/m2026-02-23, From 2024-01-01
2023-12-31-$4.62n/m2026-02-23, From 2023-01-01
2022-12-31-$2.52n/m2025-02-25, From 2022-01-01
2021-12-31-$0.67n/m2023-03-17, From 2021-01-01
2020-12-31-$4.32n/a2022-03-14, From 2020-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Tarsus Pharmaceuticals, Inc. (TARS)2025-12-31-$1.59n/m
Immunocore Holdings plc (IMCR)2025-12-31-$0.71n/m
ADMA Biologics, Inc. (ADMA)2025-12-31$0.60-25.9%
Krystal Biotech, Inc. (KRYS)2025-12-31$6.84+128.0%
Twist Bioscience Corp (TWST)2025-09-30-$1.30n/m
Adaptive Biotechnologies Corp (ADPT)2025-12-31-$0.39n/m
Vericel Corp (VCEL)2025-12-31$0.32+60.0%
Repligen Corp (RGEN)2025-12-31$0.86n/m
Iovance Biotherapeutics, Inc. (IOVA)2025-12-31-$1.09n/m

Compare TARS, IMCR, ADMA, KRYS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗